PharmaShots | Incisive News in 3 Shots

Subscribe Now

Study 309 Trial

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment of Advanced Endometrial Cancer at SGO

Merck Presents Results of Keytruda (pembrolizumab) + Lenvima (lenvatinib) in P-III KEYNOTE-775/Study 309 trial for the Treatment o...

March 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us